Search research articles
Contact Us
Filters
Showing results (41-50 of 74) with videos related to
Page
of 8
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 24, 2024
Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment
Sylvain Lehmann, Susanna Schraen-Maschke, Jean-Sébastien Vidal, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
February 16, 2022
Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles
Constance Delaby, Daniel Alcolea, Christophe Hirtz, et al.
Frontiers in Aging Neuroscience
|
June 13, 2018
Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLM<sub>R</sub> Scale
Sylvain Lehmann, Constance Delaby, Guilaine Boursier, et al.
Molecular Neurodegeneration
|
October 8, 2024
Clarifying the association of CSF Aβ, tau, BACE1, and neurogranin with AT(N) stages in Alzheimer disease
Sylvain Lehmann, Susanna Schraen-Maschke, Luc Buée, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 5, 2024
Association of caffeine consumption with cerebrospinal fluid biomarkers in mild cognitive impairment and Alzheimer's disease: A BALTAZAR cohort study
David Blum, Emeline Cailliau, Hélène Béhal, et al.
Molecular Psychiatry
|
June 23, 2026
Beyond amyloid and tau: synaptic and neurodegenerative biomarkers shape MCI progression
Constance Delaby, Susanna Schraen-Maschke, Claire Paquet, et al.
Neurology
|
February 26, 2025
Comparative Performances of 4 Serum NfL Assays, pTau181, and GFAP in Patients With Amyotrophic Lateral Sclerosis
Etienne Mondesert, Constance Delaby, Elisa De La Cruz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 30, 2025
Impact of preanalytical delay on the performance of plasma Aβ42, Aβ42/40, p-tau217, and p-tau217/Aβ42 in detecting brain amyloidosis in the ALZAN cohort
Constance Delaby, Audrey Gabelle, Marie Duchiron, et al.
Ebiomedicine
|
June 13, 2025
Comparative performance of plasma pTau181/Aβ42, pTau217/Aβ42 ratios, and individual measurements in detecting brain amyloidosis
Sylvain Lehmann, Audrey Gabelle, Marie Duchiron, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 20, 2025
The ratio of plasma pTau217 to Aβ42 outperforms individual measurements in detecting brain amyloidosis
Sylvain Lehmann, Audrey Gabelle, Marie Duchiron, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 74) with videos related to
Sort By:
Page
of 8
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 24, 2024
Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment
Sylvain Lehmann, Susanna Schraen-Maschke, Jean-Sébastien Vidal, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
February 16, 2022
Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles
Constance Delaby, Daniel Alcolea, Christophe Hirtz, et al.
Frontiers in Aging Neuroscience
|
June 13, 2018
Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLM<sub>R</sub> Scale
Sylvain Lehmann, Constance Delaby, Guilaine Boursier, et al.
Molecular Neurodegeneration
|
October 8, 2024
Clarifying the association of CSF Aβ, tau, BACE1, and neurogranin with AT(N) stages in Alzheimer disease
Sylvain Lehmann, Susanna Schraen-Maschke, Luc Buée, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 5, 2024
Association of caffeine consumption with cerebrospinal fluid biomarkers in mild cognitive impairment and Alzheimer's disease: A BALTAZAR cohort study
David Blum, Emeline Cailliau, Hélène Béhal, et al.
Molecular Psychiatry
|
June 23, 2026
Beyond amyloid and tau: synaptic and neurodegenerative biomarkers shape MCI progression
Constance Delaby, Susanna Schraen-Maschke, Claire Paquet, et al.
Neurology
|
February 26, 2025
Comparative Performances of 4 Serum NfL Assays, pTau181, and GFAP in Patients With Amyotrophic Lateral Sclerosis
Etienne Mondesert, Constance Delaby, Elisa De La Cruz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
October 30, 2025
Impact of preanalytical delay on the performance of plasma Aβ42, Aβ42/40, p-tau217, and p-tau217/Aβ42 in detecting brain amyloidosis in the ALZAN cohort
Constance Delaby, Audrey Gabelle, Marie Duchiron, et al.
Ebiomedicine
|
June 13, 2025
Comparative performance of plasma pTau181/Aβ42, pTau217/Aβ42 ratios, and individual measurements in detecting brain amyloidosis
Sylvain Lehmann, Audrey Gabelle, Marie Duchiron, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 20, 2025
The ratio of plasma pTau217 to Aβ42 outperforms individual measurements in detecting brain amyloidosis
Sylvain Lehmann, Audrey Gabelle, Marie Duchiron, et al.
Page
of 8